Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07721519Not yet recruiting
Randomised, single-blind trial of ferric carboxymaltose in iron deficiency anemia (IDA) (2 arms), sponsored by Hawler Medical University. Primary endpoint: Change from Baseline in Hemoglobin (Hb) Levels. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07721519.